Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HEMOPHILIA B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04073498
What this trial is testing

The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)

Who this might be right for
Hemophilia aHemophilia B
ApcinteX Ltd 39
Testing effectiveness (Phase 2)Study completedNCT00108758
What this trial is testing

Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 23
Post-approval studies (Phase 4)Study completedNCT00002386
What this trial is testing

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Who this might be right for
HIV InfectionsHemophilia A
Merck Sharp & Dohme LLC 55
Large-scale testing (Phase 3)Study completedNCT03569891
What this trial is testing

HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients

Who this might be right for
Hemophilia B
CSL Behring 67
Early research (Phase 1)WithdrawnNCT02084810
What this trial is testing

Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia A With Inhibitors+3 more
Novo Nordisk A/S
Not applicableStudy completedNCT03619863
What this trial is testing

ATHN 7: Hemophilia Natural History Study

Who this might be right for
Hemophilia A With InhibitorHaemophilia A Without InhibitorHemophilia B With Inhibitor+1 more
American Thrombosis and Hemostasis Network 395
Not applicableStudy completedNCT02922231
What this trial is testing

Post-Marketing Surveillance (Usage Results Study) of RIXUBIS in Adult and Pediatric Patients With Haemophilia B in South Korea

Who this might be right for
Hemophilia B
Baxalta now part of Shire 57
Post-approval studies (Phase 4)Study completedNCT00108797
What this trial is testing

Trial of NovoSeven® in Haemophilia - Joint Bleeds

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 42
Large-scale testing (Phase 3)Study completedNCT00093210
What this trial is testing

Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableStudy completedNCT02634918
What this trial is testing

Ultrasonography in Hemophilic Joint Disease and Serum Markers

Who this might be right for
Hemophilia AHemophilia BHemarthroses
Northwell Health 30
Large-scale testing (Phase 3)Study completedNCT02263456
What this trial is testing

Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia B

Who this might be right for
Haemophilia B
Bio Products Laboratory
Large-scale testing (Phase 3)Active Not RecruitingNCT05662319
What this trial is testing

Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia

Who this might be right for
Hemophilia
Sanofi 91
Not applicableWithdrawnNCT06634836
What this trial is testing

Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B

Who this might be right for
Hemophilia AHemophilia B
Pfizer
Early research (Phase 1)Ended earlyNCT01191372
What this trial is testing

First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia Patients

Who this might be right for
Hemophilia
Baxalta now part of Shire 17
Not applicableStudy completedNCT01830712
What this trial is testing

A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 15
Not applicableStudy completedNCT00936845
What this trial is testing

Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study

Who this might be right for
Hemophilia AHemophilia B
Weill Medical College of Cornell University 22
Not applicableUnknownNCT05889754
What this trial is testing

Reliability and Validity of the Turkish Version of the PedHAL

Who this might be right for
HemophiliaHemophilia A, SevereHemophilia B
Hasan Kalyoncu University 50
Not applicableStudy completedNCT03507582
What this trial is testing

Virtual Reality for Hemophilia

Who this might be right for
Hemophilia AHemophilia B
Nationwide Children's Hospital 25
Not applicableEnrolling By InvitationNCT03745924
What this trial is testing

A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

Who this might be right for
Haemophilia B
Novo Nordisk A/S 60
Not applicableStudy completedNCT07425327
What this trial is testing

Validity and Reliability of the Two-minute Step Test in Hemophilia

Who this might be right for
HemophiliaStepReliability and Validity+1 more
Hasan Kalyoncu University 31
Next Page